Bruce N. Jacobs Kymera Therapeutics, Inc. (KYMR) insider trading activity

Bruce N. Jacobs is Chief Financial Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 201,886 shares of KYMR, which is worth approximately $6.57 Million. The most recent transaction as insider was on Mar 15, 2021, when has been sold 8,195 shares (Common Stock) at a price of $2.08 per share, resulting in proceeds of $17,046. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K

19.78% 3M change

41.82% 12M change

Total Value Held $6.57 Million

Bruce N. Jacobs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2021	BUY Exercise of conversion of derivative security	$17,046 $2.08 p/Share	8,195 Added 50.0%	8,195 Common Stock
Mar 11 2021	SELL Open market or private sale	$108,426 $60.07 p/Share	1,805 Reduced 100.0%	0 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	$3,754 $2.08 p/Share	1,805 Added 50.0%	1,805 Common Stock
Mar 08 2021	SELL Open market or private sale	$513,000 $51.3 p/Share	10,000 Reduced 100.0%	0 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$20,800 $2.08 p/Share	10,000 Added 50.0%	10,000 Common Stock
Mar 03 2021	SELL Open market or private sale	$899,600 $44.98 p/Share	20,000 Reduced 100.0%	0 Common Stock
Mar 03 2021	BUY Exercise of conversion of derivative security	$41,600 $2.08 p/Share	20,000 Added 50.0%	20,000 Common Stock

BNJ

Bruce N. Jacobs

Chief Financial Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account